Welcome to the second half of the year! Lanstead gone, tax selling gone- no more reasons for the sp to sit at the current level. We've got ROW deal hopefully announced this quarter and possibly even more deals given everything is up for grabs. Also this half we have Trof P3 commencement and orphan drug designation hopefully granted along with perhaps some more pre-clinical results for NNZ-2591. Can't deny that it's going to be a big 6 months. Moet at the Christmas dinner or a clean skin?
2H
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.17 |
Change
0.070(0.35%) |
Mkt cap ! $2.578B | |||
| Open | High | Low | Value | Volume |
| $20.39 | $20.53 | $20.14 | $4.102M | 202.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 249 | $20.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.31 | 790 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |